✦ LIBER ✦

Long-term immunogenicity and safety of an inactivated hepatitis A vaccine in haemophilic patients

✍ Scribed by PIETRO DENTICO; NICOLA CIAVARELLA; FRANCESCO A. SCARAGGI; MARIO SCHIAVONI; ANNA VOLPE; ANTONIO FASANO; ANTONIA PERRICCI; ROSALBA BUONGIORNO

Book ID: 108769338
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 318 KB
Volume: 2
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.1996.tb00008.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term immunogenicity of an inactivat

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine

✍ P.A. Bovier; J. Bock; L. Loutan; T. Farinelli; R. Glueck; C. Herzog 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract The aim of this study was to predict the long‐term protection induced after immunisation with inactivated, aluminium‐free virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and

Inactivated hepatitis A vaccine: Reactog

Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence

✍ Dr. P. van Damme; S. Thoelen; M. Cramm; K. de Groote; A. Safary; A. Meheus 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Abstract This trial evaluated the reactogenicity, kinetics of antibody induction, and long‐term immunogenicity of a 720 enzyme‐linked immunosorbent assay units (EL. U.) antigen dose of an inactivated hepatitis A vaccine (Havrix(tm), SmithKline Beecham Biologicals, Rixensart, Belgium). One hundre

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Immunogenicity and safety of a new inact

Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study

✍ Dr. Christian Goilav; Jane Zuckerman; Michael Lafrenz; Emmanuel Vidor; Sabine La 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

## Abstract A multicentre, controlled, randomised, open, comparative trial including 839 healthy adult volunteers was carried out in order to compare the immunogenicity and reactogenicity of two vaccines against hepatitis A virus (HAV) during primary immunization and after booster injection. The fi

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old

✍ J. Arístegui; E. Garrote; J. L. Morales; Maria S. Gallego; R. Dal-Ré; A. Gonzále 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 861 KB

Immunogenicity and safety of an inactiva

Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men

✍ Dr. Georg Hess; Ralf Clemens; Ulrich Bienzle; Christian Schönfeld; Birgit Schunc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

The immunogenicity, reactogenicity, and safety of an inactivated hepatitis A vaccine were assessed in anti-HIV positive homosexual men. Fourteen anti-HIV positive (group 1) and 20 anti-HIV negative (group 2) men received vaccine (containing 720 ELISA units of hepatitis A antigen per dose) intramuscu